Oncology/Hematology

Myeloma

More in Myeloma

World's Smallest Skin Cancer; Exercise Boosts Immune Cells; Cannabis and Pain Relief

News, features, and commentary about cancer-related issues

May 05, 2023
Onco Break over a computer rendering of a cancer cell.
Blood, Breast Cancer Survivors Stand Out for Heart Risks Over a Decade Later

Research suggests cancer-specific precision monitoring and risk stratification

Apr 19, 2023
A photo of a mature woman holding a pink breast cancer ribbon.
Novel Antibody Induces Durable Responses in Heavily Pretreated Myeloma

Overall response rate of 90% in patients who received highest doses of REGN5459

Apr 18, 2023
AACR over a photo of Orange County Convention Center in Orlando, Florida.
CAR-T Makes Its Case for Earlier Use in Multiple Myeloma

Ide-cel tripled median PFS versus standard regimens in phase III study

Feb 10, 2023
A computer rendering of CAR T-cells attacking a cancer cell.
Novel 'Off the Shelf' CAR-T Product Shows Promise in Myeloma

Researchers say safety, efficacy of ALLO-715 comparable to autologous anti-BCMA products

Feb 02, 2023
A computer rendering of CAR T-cell immunotherapy.
ODAC to Review Lymphoma Drug; Tobacco Control; Artificial Skin Aids Cancer Studies

News, features, and commentary about cancer-related issues

Jan 27, 2023
Onco Break over a computer rendering of a cancer cell.
Post-Transplant Triplet Bests Lenalidomide Maintenance Alone in Myeloma

Longer PFS with carfilzomib, lenalidomide, and dexamethasone, interim analysis shows

Jan 17, 2023
A micrograph of multiple myeloma cells.
Off-the-Shelf T-Cell Therapy Effective Against Viral Infections After Allo-HCT

Produced an antiviral response in 95% of patients with six different types of infection

Jan 13, 2023
A computer rendering of T-cells attacking viruses
Cancer Survivors Say No to HPV Vax; Costly Prostate Cancer; Acupressure Aids Sleep

News, features, and commentary about cancer-related issues

Dec 29, 2022
Onco Break over a computer rendering of a cancer cell.
Upfront Transplant Prevails Again in Newly Diagnosed Myeloma

But U.K. trial suggests MRD assessment after induction could potentially help guide treatment

Dec 20, 2022
A photo of a bag of hematopoietic stem cells
Bispecific Antibodies in Blood Cancers; Exercise and Cognitive Function

Also in TTHealthWatch: vigorous intermittent lifestyle physical activity

Dec 17, 2022
TTUHSC EL PASO HEALTHWATCH with their logo and photos of Rick Lange, MD, and Elizabeth Tracey
Talquetamab Offers New Hope in Relapsed/Refractory Multiple Myeloma

Bispecific antibody achieves "incredible" response rates over 70% in heavily pretreated patients

Dec 11, 2022
ASH over a photo of Ernest N. Morial Convention Center in New Orleans, Louisiana.
Rigid In-Hospital Diet Offers No Advantage in Patients After HSCT

"We should eliminate these silly neutropenic diets," expert says

Dec 10, 2022
ASH over a photo of Ernest N. Morial Convention Center in New Orleans, Louisiana.
Lung Screening Saves Lives; Clues to Hyperprogression; Bacteria Foil Immunotherapy

News, features, and commentary about cancer-related issues

Nov 25, 2022
Onco Break over a computer rendering of a cancer cell.
More in Myeloma

Continuing Medical Education

0.50 CME Credits
Optimizing Outcomes in Gastroesophageal Cancers: Expert Insights on Novel Biomarkers and Therapies

1.00 CME Credits
A Deep Dive on Novel and Emerging Evidence in the Treatment of HR+/HER2- Breast Cancer

1.00 CME Credits
Leveraging Expert-Informed Adverse Event Management and Supportive Care Strategies to Improve Patient Outcomes in Bladder Cancer

0.50 CME Credits
Integrating Novel Classes of Immunotherapy Into Treatment Paradigms in Advanced/Metastatic Melanoma

0.50 CME Credits
Immunotherapy in Advanced Melanoma: Evidence-Based Adverse Event Management Strategies to Improve Patient Outcomes

1.00 CME Credits
Expert Perspectives in Managing Lower-Risk Myelodysplastic Syndromes

1.00 CME Credits
Incorporating Recent Data Into Current Treatment Paradigms in Melanoma

0.50 CME Credits
Evidence-Based Strategies to Improve Outcomes for Patients With Gastroesophageal Cancers